Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Changes in Net Assets

v3.24.0.1
Consolidated Statements of Changes in Net Assets - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Increase (Decrease) in Stockholders' Equity [Roll Forward]      
Balance at beginning of period (in shares) 84,830,679    
Balance at beginning of period $ 2,108,586 $ 1,788,846 $ 1,514,767
Public offering of common stock, net of offering costs 203,683 265,620 98,889
Share‑based compensation 16,520 13,629 10,887
Purchase of vested stock for employee payroll tax withholding $ (5,950) $ (4,943) $ (5,303)
Dividend reinvestment (in shares) 765,427 625,196 404,384
Dividend reinvestment $ 30,719 $ 24,131 $ 16,283
Amortization of directors’ deferred compensation 434 519 652
Issuance of restricted stock, net of forfeited shares 0 0 0
Dividends to stockholders (305,040) (220,822) (178,091)
Reclassification for certain permanent book-to-tax differences 0 0 0
Net increase resulting from operations $ 428,447 $ 241,606 330,762
Balance at ending of period (in shares) 78,463,599 84,830,679  
Balance at ending of period $ 2,477,399 $ 2,108,586 $ 1,788,846
Common Stock      
Increase (Decrease) in Stockholders' Equity [Roll Forward]      
Balance at beginning of period (in shares) 78,506,816 70,737,021 67,762,032
Balance at beginning of period $ 784 $ 707 $ 677
Public offering of common stock, net of offering costs (in shares) 5,159,479 6,763,166 2,345,554
Public offering of common stock, net of offering costs $ 52 $ 67 $ 24
Purchase of vested stock for employee payroll tax withholding (in shares) (151,058) (116,177) (134,238)
Purchase of vested stock for employee payroll tax withholding $ (1) $ (1) $ (1)
Dividend reinvestment (in shares) 765,427 625,196 404,384
Dividend reinvestment $ 8 $ 6 $ 4
Issuance of restricted stock, net of forfeited shares (in shares) 552,338 497,610 359,289
Issuance of restricted stock, net of forfeited shares $ 5 $ 5 $ 3
Balance at ending of period (in shares) 84,833,002 78,506,816 70,737,021
Balance at ending of period $ 848 $ 784 $ 707
Additional Paid‑In Capital      
Increase (Decrease) in Stockholders' Equity [Roll Forward]      
Balance at beginning of period 2,030,531 1,736,346 1,615,940
Public offering of common stock, net of offering costs 203,631 265,553 98,865
Share‑based compensation 16,520 13,629 10,887
Purchase of vested stock for employee payroll tax withholding (5,949) (4,942) (5,302)
Dividend reinvestment 30,711 24,125 16,279
Amortization of directors’ deferred compensation 434 519 652
Issuance of restricted stock, net of forfeited shares (5) (5) (3)
Dividends to stockholders 623 466 406
Reclassification for certain permanent book-to-tax differences (5,947) (5,160) (1,378)
Balance at ending of period 2,270,549 2,030,531 1,736,346
Total Undistributed Earnings      
Increase (Decrease) in Stockholders' Equity [Roll Forward]      
Balance at beginning of period 77,271 51,793 (101,850)
Dividends to stockholders (305,663) (221,288) (178,497)
Reclassification for certain permanent book-to-tax differences 5,947 5,160 1,378
Net increase resulting from operations 428,447 241,606 330,762
Balance at ending of period $ 206,002 $ 77,271 $ 51,793